Def defines a conserved nucleolar pathway that leads p53 to proteasome-independent degradation

Cell Research

Volumn 23, Issue 5, 2013, Pages 620-634

  Tao, Ting ^a   Shi, Hui ^a   Guan, Yihong ^a   Huang, Delai ^a   Chen, Ye ^a   Lane, David P ^c   Chen, Jun ^b   Peng, Jinrong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

133p53 113p53; Calpain; Def; digestive organ development; nucleolus; p53; ubquitination

Indexed keywords

DANIO RERIO;

CALPAIN; DIGESTIVE-ORGAN EXPANSION FACTOR, ZEBRAFISH; PROTEASOME; PROTEIN MDM2; PROTEIN P53; SMALL INTERFERING RNA; ZEBRAFISH PROTEIN;

ANIMAL; ANIMAL EMBRYO; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CYCLE G1 PHASE; CELL LINE; CHEMISTRY; GENETICS; HEPG2 CELL LINE; HUMAN; MCF 7 CELL LINE; METABOLISM; MUTATION; NUCLEOLUS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; UBIQUITINATION; UPREGULATION; ZEBRA FISH;

ANIMALS; APOPTOSIS; CALPAIN; CELL LINE; CELL NUCLEOLUS; EMBRYO, NONMAMMALIAN; G1 PHASE; HEP G2 CELLS; HUMANS; MCF-7 CELLS; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-MDM2; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION; UP-REGULATION; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84877144820     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.16     Document Type: Article

References (36)

1. Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ 2006; 13:1027-1036.
2. Tai E, Benchimol S. TRIMming p53 for ubiquitination. Proc Natl Acad Sci USA 2009; 106:11431-11432.
3. Tsvetkov P, Reuven N, Shaul Y. Ubiquitin-independent p53 proteasomal degradation. Cell Death Differ 2010; 17:103-108.
4. Pariat M, Carillo S, Molinari M, et al. Proteolysis by calpains: a possible contribution to degradation of p53. Mol Cell Biol 1997; 17:2806-2815.
5. Kubbutat MH, Vousden KH. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol Cell Biol 1997; 17:460-468.
6. Gonen H, Shkedy D, Barnoy S, Kosower NS, Ciechanover A. On the involvement of calpains in the degradation of the tumor suppressor protein p53. FEBS Lett 1997; 406:17-22.
7. Qin Q, Liao G, Baudry M and Bi X. Role of calpain-mediated p53 truncation in semaphorin 3A-induced axonal growth regulation. Proc Natl Acad Sci USA 2012; 107:13883-13887.
8. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D. Nu-cleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1999; 1:20-26.
9. Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolf PP. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol 2004; 6:665-672.
10. Dai MS, Lu H. Inhibition of MDM2-mediated p53 ubiquitina-tion and degradation by ribosomal protein L5. J Biol Chem 2004; 279:44475-44482.
11. Lohrum MAE, Ludwig RL, Kubbutat MHG, Hanlon M, Vous-den KH. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003; 3:577-587.
12. Fumagalli S, Ivanenkov VV, Teng T, Thomas G. Suprainduc-tion of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev 2012; 26:1028-1040.
13. Chen J, Ruan H, Ng SM, et al. Loss of function of def selectively up-regulates Delta113p53 expression to arrest expansion growth of digestive organs in zebrafsh. Genes Dev 2005; 19:2900-2911.
14. Charette JM, Baserga SJ. The DEAD-box RNA helicase-like Utp25 is an SSU processome component. RNA 2010; 16:2156-2169.
15. Goldfeder MB, Oliveira CC. Utp25p, a nucleolar Saccharo-myces cerevisiae protein, interacts with U3 snoRNP subunits and affects processing of the 35S pre-rRNA. FEBS J 2010; 277:2838-2852.
16. Harscoet E, Dubreucq B, Palauqui JC, Lepiniec L. NOF1 encodes an Arabidopsis protein involved in the control of rRNA expression. PLoS One 2010; 5:e12829.
17. Chen J, Ng SM, Chang C, et al. p53 isoform delta113p53 is a p53 target gene that antagonizes p53 apoptotic activity via BclxL activation in zebrafsh. Genes Dev 2009; 23:278-290.
18. Bourdon JC, Fernandes K, Murray-Zmijewski F, et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005; 19:2122-2137.
19. Aoubala M, Murray-Zmijewski F, Khoury MP, et al. p53 directly transactivates Delta133p53alpha, regulating cell fate outcome in response to DNA damage. Cell Death Differ 2011; 18:248-258.
20. Boldrup L, Bourdon JC, Coates PJ, Sjostrom B, Nylander K. Expression of p53 isoforms in squamous cell carcinoma of the head and neck. Eur J Cancer 2007; 43:617-623.
21. Ebrahimi M, Boldrup L, Coates PJ, Wahlin YB, Bourdon JC, Nylander K. Expression of novel p53 isoforms in oral lichen planus. Oral Oncol 2008; 44:156-161.
22. Libault M, Tessadori F, Germann S, Snijder B, Fransz P, Gaudin V. The Arabidopsis LHP1 protein is a component of euchromatin. Planta 2005; 222:910-925.
23. Boisvert FM, van KS, Navascues J, Lamond AI. The multifunctional nucleolus. Nat Rev Mol Cell Biol 2007; 8:574-585.
24. Billy E, Wegierski T, Nasr F, Filipowicz W. Rcl1p, the yeast protein similar to the RNA 3′-phosphate cyclase, associates with U3 snoRNP and is required for 18S rRNA biogenesis. EMBO J 2000; 19:2115-2126.
25. Berghmans S, Murphey RD, Wienholds E, et al. tp53 mutant zebrafsh develop malignant peripheral nerve sheath tumors. Proc Natl Acad Sci USA 2005; 102:407-412.
26. Dai C, Gu W. p53 post-translational modifcation: deregulated in tumorigenesis. Trends Mol Med 2010; 16:528-536.
27. Langheinrich U, Hennen E, Stott G, Vacun G. Zebrafish as a model organism for the identification and characterization of drugs and genes affecting p53 signaling. Curr Biol 2002;12:2023-2028.
28. Bykov VJ, Issaeva N, Shilov A, et al. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nat Med 2002; 8:282-288.
29. Malcikova J, Tichy B, Damborsky J, et al. Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation. Biol Chem 2010; 391:197-205.
30. Sorimachi H, Hata S, Ono Y. Impact of genetic insights into calpain biology. J Biochem 2011; 150:23-37.
31. Moretti D, Del BB, Cosci E, Biagioli M, Miracco C, Mael-laro E. Novel variants of muscle calpain 3 identifed in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions. Carcinogenesis 2009; 30:960-967.
32. Sorimachi H, Toyama-Sorimachi N, Saido TC, et al. Muscle-specifc calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem 1993; 268:10593-10605.
33. Kramerova I, Kudryashova E, Tidball JG, Spencer MJ. Null mutation of calpain 3 (p94) in mice causes abnormal sarco-mere formation in vivo and in vitro. Hum Mol Genet 2004; 13:1373-1388.
34. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-1599.
35. O'Connell MP, Fiori JL, Baugher KM, et al. Wnt5A activates the calpain-mediated cleavage of flamin A. J Invest Dermatol 2009; 129:1782-1789.
36. Jang HS, Lal S, Greenwood JA. Calpain 2 is required for glio-blastoma cell invasion: regulation of matrix metalloproteinase 2. Neurochem Res 2010; 35:1796-1804.